ArticleJournal of hazardous materials2025
Thermal treatment of hexafluoropropylene oxide dimer acid (HFPO-DA) using a pilot-scale research combustor.
Article in Journal of hazardous materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The thermal decomposition of single-component aqueous solutions of hexafluoropropylene oxide dimer acid (HFPO-DA), a "GenX" process chemical, was investigated in a pilot-scale research combustor. Two solutions containing target HFPO-DA concentrations of ∼500 and 4000 mg/L were atomized at three post-flame temperatures of ∼920, 860, and 750 °C, during which the stack gases were characterized for combustion products including fluorocarbon products of incomplete combustion (PICs). Analytical techniques included Other Test Method 50 (OTM-50) and real-time analysis using Fourier transform infrared spectroscopy (FTIR) and chemical ionization mass spectrometry (CIMS). Quantum chemical calculations were performed to identify pathways for the thermal decomposition of HFPO-DA. Identified PICs included 1H-perfluoroalkanes, fluoroether E-1 (heptafluoropropyl 1,2,2,2-tetrafluoroethyl ether), and two ultra short-chain perfluorocarboxylic acids (PFCAs): trifluoroacetic acid (TFA) and perfluoropropionic acid (PFPrA). Most PIC concentrations increased with decreasing peak temperatures with ∼40-60 % of the fluorine in the HFPO-DA converted into PICs at the lowest peak temperature examined (∼750 °C). At higher peak temperatures, lower PIC concentrations were observed, suggesting that temperature is a critical parameter for mineralization. Modeling results proposed that the thermal decomposition of HFPO-DA can pass through 1,1,1,2,2,3,3-heptafluoro-3-[(1,2,2-trifluoroethenyl)oxy]propane (perfluoropropylvinyl ether, or PPVE) or fluoroether E-1 intermediate species with the PPVE route offering lower energy barriers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.